CRYBG1 Gene

Name crystallin beta-gamma domain containing 1
Description Predicted to enable carbohydrate binding activity. [provided by Alliance of Genome Resources, Mar 2025]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nCRYBG1, also known as AIM1, is a member of the βγ‐crystallin superfamily that contains multiple conserved crystallin motifs. Structural studies of its variant domain (AIM1g1) have shown that despite significant sequence divergence from canonical βγ‐crystallins, CRYBG1 retains the overall Greek key fold and exhibits unique surface loop features that facilitate calcium binding. These adaptations may provide the structural basis for its novel biological roles."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the context of cancer, CRYBG1/AIM1 has been implicated as a tumor suppressor, particularly in melanoma. Genetic alterations—including deletions and promoter hypermethylation—have been correlated with diminished expression of CRYBG1 in aggressive malignancies. Epigenetic modifications affecting CRYBG1 accompany similar deregulation of other cell cycle regulators and transcription factors, suggesting that its loss or inactivation contributes to tumorigenesis and disease progression."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "3", "end_ref": "5"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond melanoma, altered CRYBG1 expression has also been observed in prostate cancers, where integrated gene expression and RNAi screening studies support its involvement in modulating oncogenic pathways and cellular survival. Furthermore, investigations into the mechanistic basis of its function reveal that calcium-dependent conformational dynamics and the interplay between its structural domains can compensate for potential instabilities, thereby maintaining proper protein function. These findings underscore the multifaceted role of CRYBG1 in both structure–function relationships and tumor biology."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": ""}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Penmatsa Aravind, Bheemreddy Rajini, Yogendra Sharma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Crystallization and preliminary X-ray crystallographic investigations on a betagamma-crystallin domain of absent in melanoma 1 (AIM1), a protein from Homo sapiens."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Crystallogr Sect F Struct Biol Cryst Commun (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1107/S1744309106005380"}], "href": "https://doi.org/10.1107/S1744309106005380"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16511323"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16511323"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Penmatsa Aravind, Graeme Wistow, Yogendra Sharma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exploring the limits of sequence and structure in a variant betagamma-crystallin domain of the protein absent in melanoma-1 (AIM1)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jmb.2008.06.019"}], "href": "https://doi.org/10.1016/j.jmb.2008.06.019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18582473"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18582473"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "J Iqbal, C Kucuk, R J Deleeuw, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leukemia (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/leu.2009.3"}], "href": "https://doi.org/10.1038/leu.2009.3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19194464"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19194464"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Eli Rosenbaum, Shahnaz Begum, Mariana Brait, et al. "}, {"type": "b", "children": [{"type": "t", "text": "AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Prostate (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/pros.22461"}], "href": "https://doi.org/10.1002/pros.22461"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22127895"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22127895"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Sojun Hoshimoto, Christine T Kuo, Kelly K Chong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/jid.2012.36"}], "href": "https://doi.org/10.1038/jid.2012.36"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22402438"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22402438"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Paula Vainio, John-Patrick Mpindi, Pekka Kohonen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0039801"}], "href": "https://doi.org/10.1371/journal.pone.0039801"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22761906"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22761906"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Zackary N Scholl, Qing Li, Weitao Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Single-molecule Force Spectroscopy Reveals the Calcium Dependence of the Alternative Conformations in the Native State of a βγ-Crystallin Protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M116.729525"}], "href": "https://doi.org/10.1074/jbc.M116.729525"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27378818"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27378818"}]}]}]}
NCBI Gene ID 202
API
Download Associations
Predicted Functions View CRYBG1's ARCHS4 Predicted Functions.
Co-expressed Genes View CRYBG1's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View CRYBG1's ARCHS4 Predicted Functions.

Functional Associations

CRYBG1 has 2,975 functional associations with biological entities spanning 6 categories (functional term, phrase or reference, chemical, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 30 datasets.

Click the + buttons to view associations for CRYBG1 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Proteomics Cell lines associated with CRYBG1 protein from the CCLE Cell Line Proteomics dataset.
CellMarker Gene-Cell Type Associations cell types associated with CRYBG1 gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of CRYBG1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 cellular components containing CRYBG1 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with CRYBG1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of CRYBG1 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by CRYBG1 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with CRYBG1 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with CRYBG1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with CRYBG1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with CRYBG1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
GlyGen Glycosylated Proteins ligands (chemical) binding CRYBG1 protein from the GlyGen Glycosylated Proteins dataset.
GTEx eQTL 2025 SNPs regulating expression of CRYBG1 gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of CRYBG1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
HuBMAP ASCT+B Annotations cell types associated with CRYBG1 gene from the HuBMAP ASCT+B dataset.
HuBMAP ASCT+B Augmented with RNA-seq Coexpression cell types associated with CRYBG1 gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset.
HuBMAP Azimuth Cell Type Annotations cell types associated with CRYBG1 gene from the HuBMAP Azimuth Cell Type Annotations dataset.
IMPC Knockout Mouse Phenotypes phenotypes of mice caused by CRYBG1 gene knockout from the IMPC Knockout Mouse Phenotypes dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of CRYBG1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of CRYBG1 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by CRYBG1 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of CRYBG1 gene from the NIBR DRUG-seq U2OS MoA Box dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of CRYBG1 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of CRYBG1 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of CRYBG1 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of CRYBG1 gene from the RummaGEO Gene Perturbation Signatures dataset.
Sanger Dependency Map Cancer Cell Line Proteomics cell lines associated with CRYBG1 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of CRYBG1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of CRYBG1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with CRYBG1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.